RVMD · Insider Trading
Revolution Medicines, Inc. Common Stock
Every open-market purchase and sale reported by RVMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Alan B. Sandler | Chief Development Officer | MIXED | −309 | −$922.25K |
| 2026-09-29 | Jeff Cislini | SVP & General Counsel | Sell | −765 | −$158.60K |
| 2026-09-28 | Anthony Mancini | See Remarks | MIXED | −587 | −$638.36K |
| 2026-09-24 | Elizabeth M Anderson | Director | MIXED | −5,073 | −$1.95M |
| 2026-09-22 | Anthony Mancini | See Remarks | Sell | −1,764 | −$347.40K |
| 2026-09-18 | Jeff Cislini | SVP & General Counsel | Sell | −3,366 | −$670.63K |
| 2026-09-18 | Stephen Michael Kelsey | See Remarks | Sell | −5,569 | −$1.11M |
| 2026-09-18 | Mark A Goldsmith | See Remarks | Sell | −13,988 | −$2.79M |
| 2026-09-18 | Jack Anders | Chief Financial Officer | Sell | −4,053 | −$807.51K |
| 2026-09-18 | Alan B. Sandler | Chief Development Officer | Sell | −341 | −$67.94K |
| 2026-09-18 | Anthony Mancini | See Remarks | Sell | −1,774 | −$353.45K |
| 2026-09-18 | Margaret A Horn | Chief Operating Officer | Sell | −4,967 | −$989.61K |
| 2026-09-15 | Stephen Michael Kelsey | See Remarks | MIXED | — | −$14.87M |
| 2026-09-14 | Anthony Mancini | See Remarks | MIXED | −6,085 | −$2.84M |
| 2026-09-10 | Lorence H. Kim | Director | Sell | −17,090 | −$3.59M |
| 2026-09-02 | Lorence H. Kim | Director | Sell | −56,000 | −$11.38M |
| 2026-08-25 | Jeff Cislini | General Counsel | MIXED | −614 | −$10.78M |
| 2026-08-25 | Mark A Goldsmith | See Remarks | MIXED | −6,000 | −$17.61M |
| 2026-07-01 | Sushil Patel | Director | MIXED | −2,625 | −$938.04K |
| 2026-06-26 | Jack Anders | Chief Financial Officer | MIXED | — | −$3.00M |
| 2026-06-23 | Sushil Patel | Director | A | +1,191 | — |
| 2026-06-23 | Alexis Borisy | Director | A | +1,191 | — |
| 2026-06-23 | Flavia Borellini | Director | A | +1,191 | — |
| 2026-06-23 | Sandra Horning | Director | A | +1,191 | — |
| 2026-06-23 | Lorence H. Kim | Director | A | +1,191 | — |
| 2026-06-23 | Elizabeth M Anderson | Director | A | +1,191 | — |
| 2026-06-23 | Frank Clyburn | Director | A | +1,191 | — |
| 2023-11-14 | Thilo Schroeder | Director | A | +1,457,211 | — |
| 2023-11-14 | Alexis Borisy | Director | A | +2,091,672 | — |
| 2023-11-14 | Sandra Horning | Director | A | +90,487 | — |
| 2023-10-25 | Margaret A Horn | Chief Operating Officer | M | +7,500 | +$4.05K |
| 2023-10-24 | Mark A Goldsmith | See Remarks | M | +35,000 | +$17.15K |
| 2023-10-23 | Jack Anders | Chief Financial Officer | M | +24,524 | +$72.97K |
| 2023-10-18 | Margaret A Horn | Chief Operating Officer | MIXED | — | −$746.56K |
| 2023-10-13 | Stephen Michael Kelsey | See Remarks | Sell | −16,667 | −$484.13K |
| 2023-10-02 | Jeff Cislini | General Counsel | Sell | −2,000 | −$56.39K |
| 2023-09-20 | Jack Anders | Chief Financial Officer | Sell | −1,427 | −$44.68K |
| 2023-09-20 | Jeff Cislini | General Counsel | Sell | −1,214 | −$38.01K |
| 2023-09-20 | Mark A Goldsmith | See Remarks | Sell | −8,054 | −$252.17K |
| 2023-09-20 | Stephen Michael Kelsey | See Remarks | Sell | −2,060 | −$64.50K |
| 2023-09-19 | Margaret A Horn | Chief Operating Officer | MIXED | −2,514 | −$218.67K |
| 2023-09-06 | Jack Anders | Chief Financial Officer | MIXED | — | −$647.49K |
| 2023-09-06 | Barbara Weber | Director | MIXED | — | −$468.96K |
| 2023-09-06 | Mark A Goldsmith | See Remarks | MIXED | −10,000 | −$1.38M |
| 2023-09-01 | Margaret A Horn | Chief Operating Officer | MIXED | — | −$299.56K |
| 2023-08-17 | Margaret A Horn | Chief Operating Officer | MIXED | — | −$132.18K |
| 2023-08-03 | Stephen Michael Kelsey | See Remarks | Sell | −33,332 | −$1.03M |
| 2023-08-01 | Jeff Cislini | General Counsel | Sell | −1,500 | −$39.03K |
| 2023-06-22 | Jeff Cislini | General Counsel | Sell | −1,239 | −$31.15K |
| 2023-06-22 | Jack Anders | Chief Financial Officer | Sell | −1,249 | −$31.09K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Alexis Borisy | Director | 2,340,075 | $468.74M |
| Mark A Goldsmith | See Remarks | 861,177 | $172.50M |
| Stephen Michael Kelsey | See Remarks | 286,307 | $57.35M |
| Margaret A Horn | Chief Operating Officer | 154,571 | $30.96M |
| Jack Anders | Chief Financial Officer | 123,208 | $24.68M |
| Sandra Horning | Director | 97,765 | $19.58M |
| Alan B. Sandler | Chief Development Officer | 52,559 | $10.53M |
| Jeff Cislini | SVP & General Counsel | 51,776 | $10.37M |
| Anthony Mancini | See Remarks | 39,765 | $7.97M |
| Flavia Borellini | Director | 26,215 | $5.25M |
| Sushil Patel | Director | 21,656 | $4.34M |
| Elizabeth M Anderson | Director | 20,933 | $4.19M |
| Lorence H. Kim | Director | 16,576 | $3.32M |
| Frank Clyburn | Director | 10,929 | $2.19M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the RVMD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.